Bottle of Lies: The Inside Story of the Generic Drug Boom

by Katherine Eban

Overview

A NEW YORK TIMES BESTSELLER

New York Times 100 Notable Books of 2019

New York Public Library Best Books of 2019 

Kirkus Reviews Best Health and Science Books of 2019

Science Friday Best Books of 2019 

New postscript by the author

From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—The Jungle for pharmaceuticals

Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true?

Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects.

The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings? 

A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.

 

Product Details

ISBN-13:	9780062338792
Publisher:	HarperCollins Publishers
Publication date:	06/23/2020
Pages:	512
Sales rank:	76,832
Product dimensions:	5.90(w) x 8.80(h) x 1.30(d)

About the Author

KATHERINE EBAN, an investigative journalist, is a Fortune magazine contributor and Andrew Carnegie fellow. She has also written for Vanity Fair, the New York Times, Self, The Nation, the New York Observer and other publications. She is the author of Dangerous Doses: A True Story of Cops, Counterfeiters, and the Contamination of America’s Drug Supply, and lectures frequently on the topic of pharmaceutical integrity. Educated at Brown University and Oxford, where she was a Rhodes Scholar, she lives in Brooklyn with her husband and two daughters.

Table of Contents

Author's Note ix

About the Reporting xv

Important People and Places xvii

Prologue 1

Part I Shifting Ground

Chapter 1 The Man Who Saw Further 9

Chapter 2 The Gold Rush 17

Chapter 3 A Slum for the Rich 31

Chapter 4 The Language of Quality 41

Chapter 5 Red Flags 57

Part II India Rises

Chapter 6 Freedom Fighters 69

Chapter 7 One Dollar a Day 81

Chapter 8 A Clever Way of Doing Things 91

Chapter 9 The Assignment 101

Part III A Cat-and-Mouse Business

Chapter 10 The Global Cover-Up 121

Chapter 11 Map of the World 137

Chapter 12 The Pharaoh of Pharma 149

Part IV Making a Case

Chapter 13 Out of the Shadows 161

Chapter 14 "Do Not Give to FDA" 169

Chapter 15 "How Big Is the Problem?" 179

Chapter 16 Diamond and Ruby 195

Chapter 17 "You Just Don't Get It" 207

Part V Detectives in the Dark

Chapter 18 Congress Wakes Up 221

Chapter 19 Solving for X 233

Chapter 20 A Test of Endurance 245

Chapter 21 A Deep, Dark Well 259

Chapter 22 The $600 Million Jacket 273

Part VI The Watershed

Chapter 23 The Light Switch 293

Chapter 24 We Are the Champions 311

Chapter 25 Crashing Files 321

Chapter 26 The Ultimate Testing Laboratory 337

Part VII Reckonings

Chapter 27 Flies Too Numerous to Count 357

Chapter 28 Standing 377

Epilogue 395

Postscript 411

Acknowledgments 417

Glossary 421

Notes 427

Index 469

Editorial Reviews

Gripping...Riveting and increasingly foreboding...Eban’s pacing, along with a structure that makes this astonishingly complex story easy to follow, gives the book a rough, unforced elegance...An invaluable exposé, a reportorial tour de force and a well-turned epic.

New York Times

"An extraordinary international corporate thriller...A compelling narrative...This book is good for your health." 

Hindustan Times

This book will save lives...What Rachel Carson did for our understanding of the perils facing the environment Katherine Eban has now done for our understanding of the threats to our health from the drugs we take every day. Bottle of Lies is Katherine Eban’s masterwork of global investigative reporting.

James Risen

A shocking exposé of corporate greed, arrogance, and eagerness to exploit the weak for profit....Bottle of Lies is an important work of investigative journalism. Anyone who takes prescription drugs should read it.

Eric Schlosser

Bottle of Lies is a tour de force of dogged reporting. In her bracing, panoramic account, Katherine Eban expertly unspools a colossal fraud with momentous implications for public health...This book is so alarming in places that it reads like a dystopian medical thriller. But it’s true.

Patrick Radden Keefe

Propulsive...astounding...disturbing

NPR.org

A shocking and masterful work of global investigative reporting…. This is a book that should inform and alarm the many millions of Americans (and their doctors) who use generic drugs.” 

Overseas Press Club

Propulsive...astounding...disturbing” %COMM_CONTRIB%NPR.org

12/01/2018

Award-winning investigative reporter Eban (Dangerous Doses) details the fraud, falsified data, and dangerous cost-cutting measures plaguing the generic drugs market, leading to adulterated medications. With a 150,000-copy first printing.

Library Journal